Looking for a new broker?
Enveric Biosciences, Inc. stock is down -1.64% since 30 days ago. The next earnings date is Apr 1, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a red month, as 33.33% of the previous 3 December’s closed higher than November.
Enveric Biosciences, Inc. engages in developing various cannabinoid medicines for cancer care. Its products pipeline includes EV104 for the treatment of osteoarthritis; EVM-101 for the. treatment of cancer related distress. EV102, a cannabinoid cream for topical skin application; and EV101, a. cannabinoid and chemotherapy combination therapy.
